Grantable
Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Grant · THE PFIZER FOUNDATION INC
$150,000–$250,000
Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Grant Status: ACTIVE Funder: Pfizer, Inc. Amount: US $150,000 - US $250,000 Last Updated: January 28, 2026 Summary Overview About Pfizer External Research & Grants Pfizer…
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.